Publications by authors named "Fabienne Bellarbre"

Article Synopsis
  • The study aimed to evaluate the safety of the direct oral anticoagulant rivaroxaban compared to vitamin K antagonists (VKAs) in geriatric patients (aged ≥80) with non-valvular atrial fibrillation (AF).
  • Using data from 33 geriatric centers, researchers followed 908 patients on VKAs and 995 on rivaroxaban for up to 12 months to compare bleeding risks and other health outcomes.
  • Results showed that rivaroxaban users experienced significantly lower risks of major and intracerebral bleeding compared to VKA users, suggesting it may be a safer option for older adults in preventing strokes.
View Article and Find Full Text PDF

Background: Selection of appropriate elderly who can benefit from transcatheter aortic valve implantation (TAVI) is challenging. We evaluated the prognosis of this procedure according to the comprehensive geriatric assessment (CGA) based on the multidimensional prognostic index (MPI).

Methods: Prospective observational monocentric study from January 2013 to December 2015.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate factors leading to orthostatic hypotension (OH) in hospitalized elderly patients, particularly those showing no prior symptoms.
  • Conducted in a French academic center, it involved 131 patients tested for OH after a brief period of rest and without receiving parenteral fluids.
  • Results indicated that nearly 30% tested positive for OH, with significant associations found with conditions like diabetes, low vitamin D levels, use of certain medications, and overall health assessed by the CIRS-G score.
View Article and Find Full Text PDF

Preventing atrial fibrillation (AF) complications relies mainly on anticoagulant therapy. Still it is difficult to prescribe vitamin K antagonists (VKA) in geriatric patients with AF. In order to improve anticoagulation decision in this disease, we set up an algorithm.

View Article and Find Full Text PDF

Unlabelled: Atrial fibrillation (AF) is a major risk factor for stroke. Thromboprophylaxis with anticoagulant reduces the incidence of stroke and is warranted by the CHADS(2) recommendations when score ≥2. But such therapy remains underused particularly among elderly patients.

View Article and Find Full Text PDF